Good Cellular Defense May Be Best Offense Against Type 1 Diabetes
"Our goal is to understand the causes of Type 1 diabetes," says TSRI Professor Nora Sarvetnick, who led a study published in the April issue of the journal Nature Immunology. "The idea is that we might be able to go on and design preventive therapies."

Collaboration Reveals Details of Natural Killer T Cells
"We are basically trying to understand how the NK1.1 system works," says TSRI Associate Professor Luc Teyton, who has collaborated with Princeton University's Albert Bendelac to publish a recent Science article characterizing natural killer T cells.



After the Genome

In the first of a series of articles on the impact of the Human Genome Project, News&Views asks a number of TSRI investigators to comment on some of the various programs of research which follow that historic achievement. These include structural genomics, functional genomics, comparative genomics, glycomics, proteomics, positional cloning, and the continued search for new drug targets.